Semaglutide is indicated to improve glycaemic control in adults and is an active ingredient in brands like Ozempic. Shares of Ajanta Pharma ended 1.14% in the red in the session on Tuesday. The stock has fallen close to 11% in the year so far.
Semaglutide is indicated to improve glycaemic control in adults and is an active ingredient in brands like Ozempic. Shares of Ajanta Pharma ended 1.14% in the red in the session on Tuesday. The stock has fallen close to 11% in the year so far.